Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-11-30 | 2023-12-07 | 212001 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-01-19 | 2023-02-09 | 181588 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-04-27 | 2023-11-21 | 190680 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2020-07-23 | 2020-09-03 | 120917 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2020-09-11 | 2021-01-14 | 124098 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2020-10-15 | 2021-03-04 | 126513 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-06-16 | 2023-07-07 | 195180 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-11-30 | 2024-01-08 | 211998 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-12-14 | 2024-03-21 | 213374 |
| ACT METFORMIN | 850MG | TABLET | Resolved | 2020-10-01 | 2020-10-22 | 125455 |
| ACT METFORMIN | 500MG | TABLET | Resolved | 2020-06-25 | 2020-08-27 | 118912 |
| ACT METFORMIN | 500MG | TABLET | Resolved | 2020-04-03 | 2020-04-23 | 110806 |
| ACT METFORMIN | 850MG | TABLET | Resolved | 2020-01-17 | 2020-10-22 | 103584 |
| ACT METFORMIN | 500MG | TABLET | Resolved | 2020-04-03 | 2020-05-14 | 110803 |
| ACT METFORMIN | 500MG | TABLET | Resolved | 2020-04-03 | 2020-06-04 | 110800 |
| ACT METFORMIN | 850MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110649 |
| ACT METFORMIN | 850MG | TABLET | Resolved | 2023-01-19 | 2023-04-28 | 181594 |
| ACT METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-28 | 2024-05-09 | 223862 |
| ACT METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-05-16 | 2024-09-19 | 228143 |
| ACT METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-11-01 | 2024-02-13 | 65990 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| TEVA-RANITIDINE SOLUTION | 15MG | SOLUTION | Discontinued | 2019-04-11 | 2019-04-11 | 81304 |
| TEVA-RISEDRONATE | 150MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133905 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256079 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| TEVA-TECNAL C 1/4 | 330MG 50MG 15MG 40MG | CAPSULE | Discontinued | 2019-04-11 | 2019-04-11 | 81353 |
| TEVA-TENOFOVIR | 300MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256088 |
| TEVA-TOPISONE | 0.05% | LOTION | Discontinued | 2024-06-28 | 2024-06-29 | 231589 |
| TEVA-TOPOTECAN | 4MG | POWDER FOR SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256104 |
| TEVA-TRANDOLAPRIL | 0.5MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120021 |
| TEVA-TRANDOLAPRIL | 1MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120024 |
| TEVA-TRANDOLAPRIL | 2MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120027 |
| TEVA-TRANDOLAPRIL | 4MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120030 |
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
| TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14060 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115091 |